Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

300 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Biweekly irinotecan or raltitrexed plus 6S-leucovorin and bolus 5-fluorouracil in advanced colorectal carcinoma: a Southern Italy Cooperative Oncology Group phase II-III randomized trial.
Comella P, De Vita F, Mancarella S, De Lucia L, Biglietto M, Casaretti R, Farris A, Ianniello GP, Lorusso V, Avallone A, Cartenì G, Leo SS, Catalano G, De Lena M, Comella G. Comella P, et al. Among authors: de vita f, de lucia l, de lena m. Ann Oncol. 2000 Oct;11(10):1323-33. doi: 10.1023/a:1008375705484. Ann Oncol. 2000. PMID: 11106123 Free article. Clinical Trial.
CEOP-B/VIMB vs. promace-CytaBOM in the treatment of intermediate or high grade non-Hodgkin's lymphoma: A randomised multicenter study of Southern Italy Cooperative Group.
Lorusso V, Palmieri G, Bianco AR, Abate G, Catalano G, De Vita F, Dammacco F, Lauta VM, Lucarelli G, Polimeno G, Mantovani G, D'Aprile M, Marzullo F, De Lena M. Lorusso V, et al. Among authors: de vita f, de lena m. Int J Oncol. 2000 Jan;16(1):149-54. doi: 10.3892/ijo.16.1.149. Int J Oncol. 2000. PMID: 10601560 Clinical Trial.
Oxaliplatin plus raltitrexed and leucovorin-modulated 5-fluorouracil i.v. bolus: a salvage regimen for colorectal cancer patients.
Comella P, Casaretti R, Crucitta E, De Vita F, Palmeri S, Avallone A, Orditura M, De Lucia L, Del Prete S, Catalano G, Lorusso V, Comella G. Comella P, et al. Among authors: de vita f, de lucia l. Br J Cancer. 2002 Jun 17;86(12):1871-5. doi: 10.1038/sj.bjc.6600414. Br J Cancer. 2002. PMID: 12085178 Free PMC article. Clinical Trial.
Irinotecan plus leucovorin-modulated 5-fluorouracil I.V. bolus every other week may be a suitable therapeutic option also for elderly patients with metastatic colorectal carcinoma.
Comella P, Farris A, Lorusso V, Palmeri S, Maiorino L, De Lucia L, Buzzi F, Mancarella S, De Vita F, Gambardella A. Comella P, et al. Among authors: de vita f, de lucia l. Br J Cancer. 2003 Sep 15;89(6):992-6. doi: 10.1038/sj.bjc.6601214. Br J Cancer. 2003. PMID: 12966414 Free PMC article. Clinical Trial.
Oxaliplatin plus high-dose folinic acid and 5-fluorouracil i.v. bolus (OXAFAFU) versus irinotecan plus high-dose folinic acid and 5-fluorouracil i.v. bolus (IRIFAFU) in patients with metastatic colorectal carcinoma: a Southern Italy Cooperative Oncology Group phase III trial.
Comella P, Massidda B, Filippelli G, Palmeri S, Natale D, Farris A, De Vita F, Buzzi F, Tafuto S, Maiorino L, Mancarella S, Leo S, Lorusso V, De Lucia L, Roselli M. Comella P, et al. Among authors: de vita f, de lucia l. Ann Oncol. 2005 Jun;16(6):878-86. doi: 10.1093/annonc/mdi185. Epub 2005 Apr 18. Ann Oncol. 2005. PMID: 15837702 Free article. Clinical Trial.
Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study).
De Vita F, Giuliani F, Orditura M, Maiello E, Galizia G, Di Martino N, Montemurro F, Cartenì G, Manzione L, Romito S, Gebbia V, Ciardiello F, Catalano G, Colucci G; Gruppo Oncologico Italia Meridionale. De Vita F, et al. Ann Oncol. 2007 Aug;18(8):1354-8. doi: 10.1093/annonc/mdm128. Epub 2007 May 24. Ann Oncol. 2007. PMID: 17525087 Free article. Clinical Trial.
Modulation of 5-fluorouracil as adjuvant systemic chemotherapy in colorectal cancer: the IGCS-COL multicentre, randomised, phase III study.
De Placido S, Lopez M, Carlomagno C, Paoletti G, Palazzo S, Manzione L, Iannace C, Ianniello GP, De Vita F, Ficorella C, Farris A, Pistillucci G, Gemini M, Cortesi E, Adamo V, Gebbia N, Palmeri S, Gallo C, Perrone F, Persico G, Bianco AR. De Placido S, et al. Among authors: de vita f. Br J Cancer. 2005 Oct 17;93(8):896-904. doi: 10.1038/sj.bjc.6602800. Br J Cancer. 2005. PMID: 16222322 Free PMC article. Clinical Trial.
Update on capecitabine alone and in combination regimens in colorectal cancer patients.
Silvestris N, Maiello E, De Vita F, Cinieri S, Santini D, Russo A, Tommasi S, Azzariti A, Numico G, Pisconti S, Petriella D, Lorusso V, Millaku A, Colucci G. Silvestris N, et al. Among authors: de vita f. Cancer Treat Rev. 2010 Nov;36 Suppl 3:S46-55. doi: 10.1016/S0305-7372(10)70020-7. Cancer Treat Rev. 2010. PMID: 21129610 Review.
300 results